AmCad BioMed Market Cap

AmCad BioMed has a market cap or net worth of 848.66 million as of April 28, 2025. Its market cap has decreased by -44.72% in one year.

Market Cap

848.66M

Enterprise Value

588.89M

Revenue

53.11M

Ranking

n/a

PE Ratio

n/a

Stock Price

13.50

Market Cap Chart

Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 848.66M, a decrease of -6.29%. That is a compound annual growth rate of -0.57%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2025	854.99M	-39.60%
Dec 31, 2024	1.42B	-0.45%
Dec 29, 2023	1.42B	67.51%
Dec 30, 2022	848.88M	-17.57%
Dec 30, 2021	1.03B	0.26%
Dec 31, 2020	1.03B	-19.90%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.35B
Caliway Biopharmaceuticals	94.62B
Bora Pharmaceuticals Co., LTD.	69.01B
Lotus Pharmaceutical	55.72B
Polaris Group	28.85B
Oneness Biotech	28.83B
Lumosa Therapeutics	26.18B
Pegavision	25.23B

Market Cap Rankings